Search

Your search keyword '"Ruaro B."' showing total 306 results

Search Constraints

Start Over You searched for: Author "Ruaro B." Remove constraint Author: "Ruaro B."
306 results on '"Ruaro B."'

Search Results

1. POS0826 PREDICTORS OF RESPONSE AND LONG-TERM EFFICACY AND SAFETY OF NINTEDANIB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE: DATA FROM AN ITALIAN MULTICENTRE STUDY

3. The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis

4. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

5. Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

8. Hematopoietic Stem Cell Transplantation in Late-onset X-linked Chronic Granulomatous Disease in a Female Carrier

9. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

15. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study

21. Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

22. The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19

24. POS0890 NINTEDANIB REAL-LIFE EFFICACY AND SAFETY IN SYSTEMIC SCLEROSIS (SSc)-INTERTISTIAL LUNG DISEASE (ILD): AN ITALIAN MULTICENTRE PRELIMINARY STUDY.

28. POS1228 THE ROLE OF CHEST CT IN UNDERSTANDING INTERSTITIAL LUNG DISEASE (ILD): SYSTEMIC SCLEROSIS (SSc). VERSUS COVID-19

29. Systemic sclerosis: State of the art on clinical practice guidelines

30. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

33. Systemic sclerosis: State of the art on clinical practice guidelines

43. FRI0423 Effects of selexipag in cultured scleroderma skin fibroblasts

Catalog

Books, media, physical & digital resources